Impact of Early, Personalized Nutritional Management on 1-month Mortality After Acute Stroke

NCT ID: NCT07065929

Last Updated: 2026-01-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

3084 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-09-19

Study Completion Date

2027-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study evaluate the impact of early personalized nutritional management on 1-month mortality after acute stroke.

In the randomised centres of the interventional group (early personalized nutritional management), each patient will be assessed by a dietician within 2 days of stroke. Any swallowing problems are screened, and any barriers to eating are identified before dietary support. Patient's food intakes are recorded until the 7th day post-acute to assess their energy intake. Depending on patient's nutritional objectives, a reinforced feeding strategy comprising 2 levels is put in place, in order to prevent malnutrition: in level 1, the dietician tries to meet nutritional requirements orally, while in level 2 he can recourse to artificial nutrition in the event of failure or inability to meet requirements with oral intake alone. This strategy is started immediately after the initial assessment. Intakes are reassessed every 24 to 48 hours by the dietician in order to adapt the nutritional strategy as quickly as possible in order to cover the patient's personnalized nutritional needs.

No change in practice was required of the randomised centres in the control group.

All patients will be contacted by telephone 30 days after stroke to collect parts of the assessment criteria, while the other criteria will be collected directly from the patient's computerised medical record.

Three months after stroke, an evaluation of quality of life and modified Rankin test will be performed.

Our hypothesis is that the implementation of an individualized management of early nutritional support, aimed at compensating for the decrease in intake associated with the disease, would reduce mortality at 30 days in patients hospitalised for stroke.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Stroke

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

cluster randomisation in parallel arms
Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Interventional Group

early nutritional management

Group Type EXPERIMENTAL

Early nutritional management

Intervention Type DIETARY_SUPPLEMENT

The food ingested by patients is collected until the day 7 of the stroke so that dieticians can calculate their needs and provide a suitable diet. If this is not sufficient, a reinforced nutrition strategy (meal enrichment) is implemented.

On day 5 of the stroke, if energy intake is less than 2/3 of the energy objectives, the strategy is switched to level 2, unless it is possible to increase intake within 48 hours.

Control Group

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Early nutritional management

The food ingested by patients is collected until the day 7 of the stroke so that dieticians can calculate their needs and provide a suitable diet. If this is not sufficient, a reinforced nutrition strategy (meal enrichment) is implemented.

On day 5 of the stroke, if energy intake is less than 2/3 of the energy objectives, the strategy is switched to level 2, unless it is possible to increase intake within 48 hours.

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients ≥ 18 years of age
* With an acute, ischaemic or haemorrhagic outpatient or inpatient stroke
* NIHSS score ≥ 5
* Hospitalised in a neurology department, or Neuro Vascular Unit (NVU), or in a department where beds are dedicated to receiving post-stroke patients
* Stroke less than 2 days old
* Anticipated length of hospital stay in a participating centre ≥ 5 days
* Patient affiliated to or benefiting from a social security scheme
* Patient or close relative having given written consent to participate in the study or patient included under the emergency procedure in the absence of contactable relatives

Exclusion Criteria

* Patients treated with nutritional therapy at the time of admission (history of bariatric surgery or gastrectomy, malabsorptive pathologies such as short bowel, extensive intestinal resections, etc.).
* In a palliative situation where life expectancy is \< 3 months
* Patient taking part in another study with an impact on mortality or nutrition
* Previous inclusion in the trial
* Pregnant, breast-feeding or parturient woman
* Patient unable to follow the protocol for any reason
* Patient deprived of liberty by judicial or administrative decision
* Patient under compulsory psychiatric care
* Person under legal protection
* Poor understanding of the French language
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Angers

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Angélique CAMPION

Role: PRINCIPAL_INVESTIGATOR

University Hospital, Angers

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CH Versailles

Chesnay, Yvelines, France

Site Status RECRUITING

CHU Angers

Angers, , France

Site Status RECRUITING

CHU Caen

Caen, , France

Site Status RECRUITING

CH Cholet

Cholet, , France

Site Status RECRUITING

CHD La Roche sur Yon

La Roche-sur-Yon, , France

Site Status NOT_YET_RECRUITING

CH La Rochelle

La Rochelle, , France

Site Status RECRUITING

CH Chartres

Le Coudray, , France

Site Status RECRUITING

CHU Rouen

Rouen, , France

Site Status RECRUITING

CHU Nantes

Saint-Herblain, , France

Site Status NOT_YET_RECRUITING

CH St Malo

St-Malo, , France

Site Status RECRUITING

CHU Toulouse

Toulouse, , France

Site Status NOT_YET_RECRUITING

CHU Tours

Tours, , France

Site Status NOT_YET_RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Angélique CAMPION

Role: CONTACT

02 41 35 36 37 ext. +33

Anthéa LOIEZ

Role: CONTACT

02 41 35 36 37 ext. +33

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Lucie SEBLIN

Role: primary

01 39 63 89 69 ext. +33

Angélique CAMPION

Role: primary

0241353637 ext. +33

Agathe DELEAND

Role: primary

02 31 06 39 21 ext. +33

Mathilde POUPIN

Role: primary

02 41 49 62 89 ext. +33

Elie GUYAU

Role: primary

02 51 44 61 61 ext. +33

Charlotte VINCENT

Role: primary

05 46 45 67 62 ext. +33

Véronique LUCAS

Role: primary

02 37 30 36 28

Siriane LANDRY

Role: primary

02 32 88 89 90 ext. +33

Audrey FELTRI

Role: primary

02 44 76 84 95 ext. +33

Charline BARBE

Role: primary

02 99 21 20 78

Jérémy GEFFROY

Role: primary

05 61 77 55 69 ext. +33

Pauline CHEVE

Role: primary

02 47 47 47 47 ext. +33

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2025-A00234-45

Identifier Type: OTHER

Identifier Source: secondary_id

49RC23_0302

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Intermittent Oral Tube on Feeding Amount
NCT06328933 NOT_YET_RECRUITING NA